We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMT icon
251
Walmart Inc
WMT
$909B
$11M 0.07%
233,334
+15,198
+7% +$722K
MCO icon
252
Moody's
MCO
$83.7B
$11M 0.07%
39,516
+3,865
+11% +$1.06M
ACET icon
253
Adicet Bio
ACET
$77.6M
$11M 0.07%
76,923
-13,834
-15% -$3.45M
MRSH
254
Marsh
MRSH
$94.3B
$11M 0.07%
66,473
-77,419
-54% -$12.7M
GNW icon
255
Genworth Financial
GNW
$3.86B
$10.9M 0.07%
2,069,357
-812,657
-28% -$3.82M
RMD icon
256
ResMed
RMD
$31.1B
$10.9M 0.07%
52,475
-2,872
-5% -$631K
CAT icon
257
Caterpillar
CAT
$361B
$10.9M 0.07%
45,396
-4,574
-9% -$996K
DE icon
258
Deere & Co
DE
$165B
$10.9M 0.07%
25,333
-1,252
-5% -$509K
KRG icon
259
Kite Realty
KRG
$5.86B
$10.8M 0.07%
514,801
+230,825
+81% +$4.71M
WFC icon
260
Wells Fargo
WFC
$254B
$10.8M 0.07%
260,455
+6,684
+3% +$296K
WFG icon
261
West Fraser Timber
WFG
$5.21B
$10.7M 0.07%
148,120
+15,020
+11% +$1.15M
NWSA icon
262
News Corp Class A
NWSA
$15.6B
$10.6M 0.07%
46,492
-24,257
-34% -$421K
AVB icon
263
AvalonBay Communities
AVB
$27.5B
$10.6M 0.07%
65,553
-1,672
-2% -$285K
VIPS icon
264
Vipshop
VIPS
$7.26B
$10.6M 0.07%
+469,850
New +$4.67M
MRVL icon
265
Marvell Technology
MRVL
$147B
$10.5M 0.07%
282,953
+82,135
+41% +$3.35M
BPOP icon
266
Popular Inc
BPOP
$11B
$10.5M 0.07%
+157,966
New +$11M
RHI icon
267
Robert Half
RHI
$4.11B
$10.5M 0.07%
141,874
+10,905
+8% +$832K
BAP icon
268
Credicorp
BAP
$30.5B
$10.5M 0.07%
77,180
-22,620
-23% -$3.21M
MAR icon
269
Marriott International
MAR
$100B
$10.4M 0.07%
69,554
+51,800
+292% +$7.98M
CERE
270
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$10.3M 0.07%
327,221
-70,000
-18% -$1.98M
AGO icon
271
Assured Guaranty
AGO
$3.73B
$10.2M 0.07%
163,611
-66,749
-29% -$3.96M
KHC icon
272
Kraft Heinz
KHC
$32.8B
$10.1M 0.07%
248,598
+110,476
+80% +$4.19M
KURA icon
273
Kura Oncology
KURA
$793M
$10.1M 0.07%
814,364
+118,789
+17% +$1.73M
SHW icon
274
Sherwin-Williams
SHW
$83.5B
$10M 0.07%
42,320
-3,592
-8% -$831K
FICO icon
275
Fair Isaac
FICO
$31.8B
$10M 0.07%
16,730
+13,052
+355% +$6.87M

Similar funds

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.